High-intensity focused ultrasound (HIFU)

PROCEDURE5 trials

Sponsors

Patrick Dillon, MD, Case Comprehensive Cancer Center, Chongqing Medical University, Chinese University of Hong Kong, The First Affiliated Hospital with Nanjing Medical University

Conditions

Allergic RhinitisBreast CancerProstate AdenocarcinomaProstate CancerTriple Negative Breast Cancer (TNBC)Uterine Fibroids (UF)

Early Phase 1

Prospective Multicenter Observational Study and Promotion of the Application of Focused Ultrasound in Allergic Rhinitis

RecruitingNCT06272032

Chongqing Medical UniversityAllergic Rhinitis

Start: 2023-08-01End: 2025-07-31Target: 240Updated: 2024-02-22

Phase 1

Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer

TerminatedNCT03237572

Patrick Dillon, MDBreast Cancer

Start: 2017-09-25End: 2022-06-17Updated: 2026-02-09

Phase 2

Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.

RecruitingNCT07394387

The First Affiliated Hospital with Nanjing Medical UniversityTriple Negative Breast Cancer (TNBC)

Start: 2025-01-01End: 2026-12-31Target: 58Updated: 2026-05-15

Unknown Phase

Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

RecruitingNCT05610852

Case Comprehensive Cancer CenterProstate Adenocarcinoma, Prostate Cancer

Start: 2024-01-01End: 2028-12-01Target: 276Updated: 2026-08-06

HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids

RecruitingNCT06692335

Chinese University of Hong KongUterine Fibroids (UF)

Start: 2025-02-06End: 2027-12-31Target: 112Updated: 2026-03-27

Related Papers

Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity

Journal for ImmunoTherapy of Cancer2020-08-0153 citations

Focused ultrasound therapy combined with pembrolizumab in metastatic breast cancer.

Journal of Clinical Oncology2018-02-101 citations